Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

Blood Products in the Management of Abnormal Placentation.

Publication ,  Journal Article
Gatta, LA; Lockhart, EL; James, AH
Published in: Clin Obstet Gynecol
December 2018

A critical tool in the successful management of patients with abnormal placentation is an established massive transfusion protocol designed to rapidly deliver blood products in obstetrical and surgical hemorrhage. Spurred by trauma research and an understanding of consumptive coagulopathy, the past 2 decades have seen a shift in volume resuscitation from an empiric, crystalloid-based method to balanced, targeted transfusion therapy. The present article reviews patient blood management in abnormal placentation, beginning with optimizing the patient's status in the antenatal period to the laboratory assessment and transfusion strategy for blood products at the time of hemorrhage.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Clin Obstet Gynecol

DOI

EISSN

1532-5520

Publication Date

December 2018

Volume

61

Issue

4

Start / End Page

828 / 840

Location

United States

Related Subject Headings

  • Uterine Hemorrhage
  • Transfusion Reaction
  • Preoperative Care
  • Prenatal Care
  • Pregnancy
  • Postpartum Hemorrhage
  • Placenta Previa
  • Placenta Accreta
  • Operative Blood Salvage
  • Obstetrics & Reproductive Medicine
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gatta, L. A., Lockhart, E. L., & James, A. H. (2018). Blood Products in the Management of Abnormal Placentation. Clin Obstet Gynecol, 61(4), 828–840. https://doi.org/10.1097/GRF.0000000000000400
Gatta, Luke A., Evelyn L. Lockhart, and Andra H. James. “Blood Products in the Management of Abnormal Placentation.Clin Obstet Gynecol 61, no. 4 (December 2018): 828–40. https://doi.org/10.1097/GRF.0000000000000400.
Gatta LA, Lockhart EL, James AH. Blood Products in the Management of Abnormal Placentation. Clin Obstet Gynecol. 2018 Dec;61(4):828–40.
Gatta, Luke A., et al. “Blood Products in the Management of Abnormal Placentation.Clin Obstet Gynecol, vol. 61, no. 4, Dec. 2018, pp. 828–40. Pubmed, doi:10.1097/GRF.0000000000000400.
Gatta LA, Lockhart EL, James AH. Blood Products in the Management of Abnormal Placentation. Clin Obstet Gynecol. 2018 Dec;61(4):828–840.

Published In

Clin Obstet Gynecol

DOI

EISSN

1532-5520

Publication Date

December 2018

Volume

61

Issue

4

Start / End Page

828 / 840

Location

United States

Related Subject Headings

  • Uterine Hemorrhage
  • Transfusion Reaction
  • Preoperative Care
  • Prenatal Care
  • Pregnancy
  • Postpartum Hemorrhage
  • Placenta Previa
  • Placenta Accreta
  • Operative Blood Salvage
  • Obstetrics & Reproductive Medicine